An open, randomized pilot study to evaluate the use of basiliximab with an optimized cyclosporine dosing on renal function in de novo liver transplantation.
Phase of Trial: Phase IV
Latest Information Update: 24 Aug 2010
At a glance
- Drugs Basiliximab; Ciclosporin; Corticosteroids; Mycophenolate mofetil
- Indications Liver transplant rejection
- Focus Pharmacodynamics
- Sponsors Novartis
- 24 Aug 2010 Actual end date (April 2005) added as reported by ClinicalTrials.gov.
- 24 Aug 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 23 Oct 2006 New trial record.